Biyobelirteçler, koroner arter hastalığının şiddetini gösterebilir mi?

• Published in: Cukurova Medical Journal Vol. 46; no. 3; pp. 883 - 888
• Main Authors: Karabulut,Dilay, Karabulut,Umut, Şahingöz Erdal,Gülçin, Kasapoğlu,Pınar, Turhan,Nihan, Satilmisoglu,Muhammet Hulusi, Işıksaçan,Nilgün
• Format: Journal Article
• Language: Turkish
• Published: Çukurova Üniversitesi Tıp Fakültesi 01.03.2021
• Subjects: Tıp; Adana; Türkiye; Biomarker; myocardial infarction; miyokard enfarktüs; Biyobelirteç; SYNTAX
• ISSN: 2602-3032; 2602-3040
• DOI: 10.17826/cumj.865009

Purpose: Biomarkers are useful measures assisting the diagnosis, treatment, and prognosis of cardiovascular diseases. They can predict the severity of cardiovascular diseases, especially in acute myocardial infarction at the emergency department. We aimed to investigate the severity of cardiovascular disease using three biomarkers, namely cardiac troponins, C-reactive protein (CRP), and procalcitonin in patients with ST-elevation myocardial infarction who presented to the emergency department. Material and Methods: The study included a total of 166 patients that presented with ST-elevation myocardial infarction (STEMI) in the first three hours of symptom onset and underwent coronary angiography. SYNTAX (SS) scores were calculated, and based on these scores, two groups were formed. High-sensitivity troponin T (Hs- TnT), high-sensitivite CRP (Hs-CRP), and procalcitonin levels were measured at the presentation. Results: Although the high sensitive troponin, Hs-CRP values were higher in the SYNTAX score>20 groups, there was no statistically significant difference between the two groups. There was no significant difference in the PCT measurements between the two groups Conclusion: When Hs-TnT and Hs-CRP are evaluated together in patients with STEMI with a high SS, it may be predictive in early determining the severity of coronary artery disease.